Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma (Q37613320)
scientific article published on 27 July 2015
Language:
(P31) (Q13442814)
(P50) (Q106561774)
(Q96200428)
(Q91522188)
(Q88014314)
(Q6490646)
(Q88022461)
(Q114427964)
(Q92029679)
(Q91632799)
(Q114726224)
(Q88391157)
(P304) 463-470
(P407) (Q1860)
(P433) 4
(P478) 171
(P577) Monday, July 27, 2015
(P921) (Q25100065)
(P1433) (Q4970200)
(P1476) "Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma" (language: en)
(P2093) Lei Feng
(P2860) (Q34663617)
(Q37707078)
(Q33690142)
(Q37446311)
(Q37469133)
(Q33399582)
(Q27851678)
(Q24607479)
(Q34488779)
(Q33816583)
(Q29617685)
(Q29615530)
(Q37360125)
(Q36352100)
(Q36260264)
(Q33366976)
(Q34362034)
(Q29547860)
(Q38080710)
(Q39355339)
(Q38431323)
(Q54362642)
(Q47582438)
(Q80209074)
other details
description scientific article published on 27 July 2015

External Links